MedPath

A study to compare chloroprocaine and bupivacaine in quick walking of patients after surgery

Not yet recruiting
Conditions
Other diseases of the digestive system,
Registration Number
CTRI/2020/02/023186
Lead Sponsor
S Dhanasekar
Brief Summary

This is a randomised controlled trial to evaluate the duration of analgesia, early mobilisation, analgesia efficacy, safety features of chloroprocaine with hyperbaric bupivacaine in short durational surgeries among 60 patients over a period of 18 months. The primary objective is to find the time taken for first / early mobilisation of patient post operatively. The secondary outcomes are duration of analgesia, hemodynamic changes, urinary retention, transient neurological symptom.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients undergoing elective short durational surgeries ( TURP, DJ Stenting, URSL, Perianal abscess, Gluteal abscess, LAS ) American Society of Anaesthesiologist I or II Patient willing for regional anaesthesia and fear of general anaesthesia.

Exclusion Criteria

Patient refusal for spinal anaesthesia Coagulopathy or bleeding diathesis Infection at the site of injection Sepsis Pre existing neurological deficit Severe hypovolemia Chronic renal disorder ( hypervolemia, acidosis, hypernatremia ).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time taken for first / early mobilisation of patientPost Operative Period
Secondary Outcome Measures
NameTimeMethod
Duration of analgesiaHemodynamic changes

Trial Locations

Locations (1)

Shri Sathya Sai Medical College and Research Institute

🇮🇳

Kancheepuram, TAMIL NADU, India

Shri Sathya Sai Medical College and Research Institute
🇮🇳Kancheepuram, TAMIL NADU, India
S Dhanasekar
Principal investigator
9176451198
dr.dhanasekar89@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.